The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma
Abstract
CONTEXT: Adrenocortical carcinomas are uncommon, and their evaluation by [(18)F]fluorodeoxyglucose positron emission tomography (FDG PET) has not been well evaluated. OBJECTIVE: The purpose of this study was to examine the potential utility of FDG PET in the detection of recurrent or metastatic adrenocortical carcinoma. DESIGN: In patients with known adrenocortical carcinoma who underwent FDG-PET imaging for suspected recurrence or metastasis, FDG activity was compared with other imaging findings, clinical features, and the presence or absence of disease as confirmed by resection, biopsy, or clinical follow-up. SETTING: The study took place at four tertiary referral centers. PATIENTS OR OTHER PARTICIPANTS: Twelve patients (10 females and two males, 5-71 yr of age) were evaluated. MAIN OUTCOME MEASURES: The main outcome measures were FDG activity, other imaging findings, and clinical features. RESULTS: Abnormal FDG uptake correctly indicated tumor recurrence in 10 patients. One patient with no abnormal FDG activity had a morphological abnormality subsequently proven to be a postoperative scar. Two patients, one with very small pulmonary lesions and one with a hepatic metastasis, had false-negative findings. CONCLUSIONS: Most adrenocortical carcinomas accumulate and retain FDG and thus can be visualized by PET. However, false-negative findings are possible, especially with very small lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensity of FDG uptake was found to be related to survival in patients with ACC, with a maximum SUV of >10 indicating poor prognosis (111).”
From Adrenocortical carcinoma (2014) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
CT time-attenuation washout curves of adrenal adenomas and nonadenomas
Korobkin, M., Brodeur, F. J., Francis, I. R., Quint, L. E., Dunnick, N. R., & Londy, F. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.3.9490968 · Cited by 386
Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
KOROBKIN, M. T., Brodeur, F. J., Yutzy, G. G., Francis, I. R., Quint, L. E., Dunnick, N. R., & Kazerooni, E. A. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.166.3.8623622 · Cited by 364
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun, M., Kim, W., Alnafisi, N., Lacorte, L., Jang, S., & Alavi, A. A. (2001) · PubMed · Cited by 336
Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
Mitchell, D. G., Crovello, M., Matteucci, T., Petersen, R. O., & Miettinen, M. (1992) · Radiology · doi:10.1148/radiology.185.2.1410337 · Cited by 333
Erasmus, J. J., Patz, E. F., McAdams, H. P., Murray, J. G., Herndon, J. E., Coleman, R. E., & Goodman, P. C. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.5.9129444 · Cited by 330
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy- d -glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 303
Boland, G. W., Goldberg, M. A., Lee, M. J., Mayo-Smith, W. W., Dixon, J., McNicholas, M. M. J., & Müeller, P. R. (1995) · Radiology · doi:10.1148/radiology.194.1.7997539 · Cited by 222
Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
Szolar, D. H., & Kammerhuber, F. (1998) · Radiology · doi:10.1148/radiology.207.2.9577483 · Cited by 218
Flagged first, then by citations
2 of the 29 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–115 of 115
Hormoninaktive Nebennierenadenome
Ladurner, R., & Hallfeldt, K. K. J. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_30-1
Gamie, S. H., Yevdayev, E., Kaushik, A., & Lai, H. (2015) · Springer eBooks · doi:10.1007/978-1-4419-5811-2_14
Jadvar, H., & Shulkin, B. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-21371-2_17
Vorwerk, P., Redlich, A., & Mohnike, K. L. (2016) · Springer eBooks · doi:10.1007/978-3-662-48842-3_13
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37708-9.50031-3
A Rare Tumor in a Rare Location: Ganglioneuroma
Mouhafid, F. E., Hajoujji, A., Abdelmounaime, A. A., & Zentar, A. (2022) · Surgical Science · doi:10.4236/ss.2022.136037
Hormoninaktive Nebennierenadenome
Ladurner, R., & Hallfeldt, K. K. J. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-63317-5_30
Roy, D., Pereira, M., Shivdasani, D., Singh, N., Dang, S., & Rungta, R. (2022) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_33_22
Adrenocortical Carcinoma in a 2 Years Old Girl, a Rare Cause of Clitoridomegaly: A Case Report
Léonidas, N., Omid, M., Helle, M. J., Kabirou, M., Diori, A., Issoufou, Y., Efared, B., Aminou, M., & Habibou, A. (2023) · Clinics of Oncology · doi:10.47829/coo.2023.7301
Adrenocortical cancer: late diagnosis of the disease on the example of a clinical case. Case report
Starostina, E. A. (2023) · Terapevticheskii arkhiv · doi:10.26442/00403660.2023.12.202430
Adrenal Multidisipliner Güncel Yaklaşım
Özen, F. Z., Özer, M., Özsoy, Ç., Binnetoğlu, E., Alparslan, A. Ş., Budak, E. S., Kök, E. V., Çetinkaya, G. S., Durmuş, M. E., Köker, G., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2992
Patil, P., Monteiro, J., Qureshi, S. S., & Karnik, N. (2024) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0044-1780522
Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan
Rey, C. R., Candil, A. O., Galván, E. V., Martín, M. N. C., & Delgado, J. L. C. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-015-0343-3
Rare Tumors of the Peripheral Nervous System
Brennan, B. M. D., Galindo, C. R., & Bisogno, G. (2011) · Pediatric oncology · doi:10.1007/978-3-642-04197-6_42
Imaging for the Differential Diagnosis of Cushing’s Syndrome: MRI, CT, and Isotopic Scanning
de Herder, W. W., & Feelders, R. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_8
Metadata
- Authors
- Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., Hurwitz, C. A., & Schteingart, D. E.
- Affiliations
- University of Michigan (US)
- St. Jude Children's Research Hospital (US)
- Department of Internal Medicine, Divisions of Hematology-Oncology (F.P.W.) Ann Arbor, Michigan 48109
- Department of Surgery (P.G.G.) Ann Arbor, Michigan 48109
- Boston Children's Hospital (US)
- Departments of Pediatrics (G.K.) St. Louis, Missouri 63110
- Hematology-Oncology (R.C.R., C.R.-G.), St. Jude Children’s Research Hospital, Memphis, Tennessee 38105
- Washington University in St. Louis (US)
- Maine Medical Center (US)
- Endocrinology and Metabolism (D.E.S.) Ann Arbor, Michigan 48109
- Corresponding author
- Shulkin, Barry L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 91
- Issue
- 7
- Pages
- 2665-2671
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2146827226
- Cited by
- 115
- References
- 29
- Citations by year
- 2024: 5 · 2023: 6 · 2022: 9 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 6 · 2012: 8
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lebanese Syrian Associated Charities
- U.S. Public Health Service
- National Cancer Institute (5R25 CA 23944, CA54216, CA21765, R25CA023944, P30CA021765)
- National Center for Research Resources (M-01RR00042, M01RR000042)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenocortical carcinoma, FDG-PET, tumor recurrence, metastasis detection, false-negative results, small pulmonary lesions, liver metastasis, postoperative scar
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Aged, Child, Child, Preschool, False Negative Reactions, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
